Thymosin α 1 potentiates the release by CD8 <sup>+</sup> cells of soluble factors able to inhibit HIV-1 and human T lymphotropic virus 1 infection <i>in vitro</i>
Claudia Matteucci(University of Rome Tor Vergata), Enrico Garaci(Istituti di Ricovero e Cura a Carattere Scientifico), Beatrice Macchi(National Cancer Institute), Stefano Aquaro(University of L'Aquila), Gabriella d’Ettorre(Policlinico Umberto I), Antonella Minutolo(University of Rome Tor Vergata), Michela Pollicita(University of Rome Tor Vergata), Emanuela Balestrieri(University of Rome Tor Vergata), Antonio Mastino(Istituto di Farmacologia Traslazionale), P Sinibaldi Vallebona(University of Rome Tor Vergata), Carlo Federico Perno(Centre International De Reference Chantal Biya), Ilaria Bucci(University of Rome Tor Vergata), Sandro Grelli(University of Rome Tor Vergata), Vincenzo Vullo(Sapienza University of Rome), Alessandra Luchini(George Mason University)
Cited by 16
Related Papers
Post-Traumatic Stress Symptoms in Healthcare Workers Dealing with the COVID-19 Pandemic: A Systematic Review
|International Journal of Environmental Research and Public Health|2021|272
Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19
|Frontiers in Medicine|2020|218
Diet Supplementation, Probiotics, and Nutraceuticals in SARS-CoV-2 Infection: A Scoping Review
|Nutrients|2020|205
Post-traumatic Stress Disorder Among COVID-19 Survivors at 3-Month Follow-up After Hospital Discharge
|Journal of General Internal Medicine|2021|159
Cardiovascular risk and dyslipidemia among persons living with HIV: a review
|BMC Infectious Diseases|2017|152